DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters.
about
Principal role of TRAP/mediator and SWI/SNF complexes in Kaposi's sarcoma-associated herpesvirus RTA-mediated lytic reactivationIdentification of direct transcriptional targets of the Kaposi's sarcoma-associated herpesvirus Rta lytic switch protein by conditional nuclear localizationThe Modulation of Apoptotic Pathways by GammaherpesvirusesKSHV reactivation and novel implications of protein isomerization on lytic switch controlSystematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus.K13 blocks KSHV lytic replication and deregulates vIL6 and hIL6 expression: a model of lytic replication induced clonal selection in viral oncogenesis.Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a SUMO E3 ligase that is SIM-dependent and SUMO-2/3-specific.Binding of RBP-Jkappa (CSL) protein to the promoter of the Kaposi's sarcoma-associated herpesvirus ORF47 (gL) gene is a critical but not sufficient determinant of transactivation by ORF50 protein.Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 RTA reactivates murine gammaherpesvirus 68 from latency.Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latencyNumber of and distance between response elements in Kaposi's sarcoma-associated herpesvirus ORF57 promoter influence its activation by replication and transcription activator and its repression by interferon regulatory factor 7.Kaposi's sarcoma-associated herpesvirus K-bZIP represses gene transcription via SUMO modification.Gene expression and transcription factor profiling reveal inhibition of transcription factor cAMP-response element-binding protein by gamma-herpesvirus replication and transcription activatorThe RBP-Jκ binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation.Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.Herpesvirus BACs: past, present, and future.Characterization of interactions between RTA and the promoter of polyadenylated nuclear RNA in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8.Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains two functional lytic origins of DNA replicationRole of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activaGlobal changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivatorViral interaction: a possible contributing factor in head and neck cancer progression.The latency-associated nuclear antigen homolog of herpesvirus saimiri inhibits lytic virus replication.Transcriptional regulation of the interleukin-6 gene of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus).Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and ReactivationMolecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesisLytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latencyThe role of Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 regulator of transcription activation (RTA) in control of gene expression.Replication and transcription activator (RTA) of murine gammaherpesvirus 68 binds to an RTA-responsive element and activates the expression of ORF18Targeted disruption of Kaposi's sarcoma-associated herpesvirus ORF57 in the viral genome is detrimental for the expression of ORF59, K8alpha, and K8.1 and the production of infectious virus.Murine Gammaherpesvirus 68 ORF48 Is an RTA-Responsive Gene Product and Functions in both Viral Lytic Replication and Latency during In Vivo Infection.Cooperation between viral interferon regulatory factor 4 and RTA to activate a subset of Kaposi's sarcoma-associated herpesvirus lytic promotersKaposi's sarcoma-associated herpesvirus/human herpesvirus 8 transcriptional activator Rta is an oligomeric DNA-binding protein that interacts with tandem arrays of phased A/T-trinucleotide motifsKaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta lytic switch protein functions as a tetramerEssential role of RBP-Jkappa in activation of the K8 delayed-early promoter of Kaposi's sarcoma-associated herpesvirus by ORF50/RTA.Tiled microarray identification of novel viral transcript structures and distinct transcriptional profiles during two modes of productive murine gammaherpesvirus 68 infection.An alternative Kaposi's sarcoma-associated herpesvirus replication program triggered by host cell apoptosis.Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression.Promoter- and cell-specific transcriptional transactivation by the Kaposi's sarcoma-associated herpesvirus ORF57/Mta protein.
P2860
Q24550587-E361E0CC-624A-4968-86EA-0D146B92BD6DQ24648127-3B4989BE-D9BE-4D63-926A-71972F9A56AFQ26747452-49563B81-B023-43D0-8BAC-09A217186CF1Q28080937-7971BE8B-977F-486E-BF02-C8927ACE2683Q33280632-90201C6B-A4AB-4C1E-A459-DFC39D0158F1Q33303677-F54844AD-2536-4270-B0B7-5EE2AC3FFFB6Q33648307-D3590D1B-F00D-49F3-97AB-06186AA24F18Q33664758-206C06E5-EA57-484D-8C7E-C98F29E30867Q33833909-CFDCE839-6216-4922-8EAA-E4D389837CF9Q33843211-02281A69-ADA7-48D5-9281-15AD36D5475AQ33858048-07CC5334-69F9-4064-9972-B4B4ACDE88AEQ33908645-E0EA7C85-95E9-4627-9538-3CE270C6A25DQ34055674-4B9683AC-DD28-4FDB-A5B1-211840F4D9DFQ34130213-90EA7C23-0AAA-4ECC-A09A-F7A283429204Q34194120-154DB604-BEAA-4678-AEE5-8339D674753BQ34247863-0CB301D3-B6E8-443C-8B3E-20B6AA25D8DAQ34338900-0DD8E70D-3FE4-4398-9840-55A3CE942FC6Q34343562-CA1B5815-0104-4A98-A7E9-87E2D90B76BCQ34461819-FEA17363-1F36-4B8C-9C27-ED5357063776Q34782463-C19217B5-F618-4AC0-890C-8DB51827DCFAQ34793397-9D2F1E82-1D30-41FE-8EF8-C9A5687A1963Q34977304-F16D3F07-D3FA-4575-BB5B-9F574078B562Q35000927-A01FB8ED-35DA-4D22-A5B3-201FF1735E8DQ35010647-8AFFCAA5-F059-449A-91DB-FB622E43F472Q35026060-347FACC2-9157-45A8-AF3E-687155032016Q35124404-6E6893B4-0C3A-48DC-906D-09858E21B872Q35168476-98051979-1A29-422A-98CA-D478B56F1CB9Q35192797-D7A72EA1-46C4-485D-928A-1842FD45E806Q35196615-D671AB12-0607-47E0-984C-EC42F65E412FQ35363402-F85618F2-3C02-4877-8DDB-CA805B9F89B8Q35635202-5C4585CB-6C5A-4F58-BDF2-0422A2CF0F19Q35641125-111CFEEE-71B8-4536-8619-39B13DEE3476Q35665832-67EDD219-26CA-40ED-9446-A321A2898176Q35803753-6C425A78-68A3-4A43-A08A-11C2295DB9A9Q35857736-5DA1C700-BCF1-4C6C-A71E-F5E210A8F836Q35867478-4A64C783-BDA6-49A6-B7CA-F72446144057Q35867993-2E4B0313-F94A-42DE-A030-ACD78114A6E7Q35868064-34C9417C-D7A1-4945-9A09-DCCFAFD3D117Q36099240-20C1EABF-E973-4DB3-8B27-FF3F3FE53F44Q36315189-EBE5F198-4AF7-4DA2-A385-DC5C19AC6868
P2860
DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
DNA binding by Kaposi's sarcom ...... viral delayed early promoters.
@ast
DNA binding by Kaposi's sarcom ...... viral delayed early promoters.
@en
type
label
DNA binding by Kaposi's sarcom ...... viral delayed early promoters.
@ast
DNA binding by Kaposi's sarcom ...... viral delayed early promoters.
@en
prefLabel
DNA binding by Kaposi's sarcom ...... viral delayed early promoters.
@ast
DNA binding by Kaposi's sarcom ...... viral delayed early promoters.
@en
P2093
P2860
P1433
P1476
DNA binding by Kaposi's sarcom ...... viral delayed early promoters.
@en
P2093
P2860
P304
P356
10.1128/JVI.75.15.6786-6799.2001
P50
P577
2001-08-01T00:00:00Z